The reason for the recall is a failure in laboratory testing; the FDA said the affected lots of medication did not dissolve as expected during tests.

Researchers assessed efficacy, safety, tolerability, cost-effectiveness, and quality of life for serial ketamine infusions vs midazolam as an adjunct to usual inpatient care.

Researchers examined associations between prenatal and first year-of-life exposure to PM2.5 components and ASD diagnosis by age 5 years.

The FDA noted that while some studies suggest a possible connection, others have found no link — acetaminophen remains the only nonprescription fever and pain reliever approved for use during pregnancy,

Researchers assessed seizure control and neuropsychiatric outcomes after epilepsy surgery in patients with both autism spectrum disorder and epilepsy.

CTx-1301 is a novel proprietary formulation of dexmethylphenidate, a stimulant that increases norepinephrine and dopamine activity in the brain.

Researchers analyzed differences in ADHD severity, its comorbidity with other psychiatric disorders, and its impact on psychosocial functioning by sex.

Researchers surveyed 100 child neurologists on their knowledge of and clinical practices addressing motor impairments in pediatric patients with ASD.

Uzedy is a subcutaneous, extended-release formulation of risperidone, an atypical antipsychotic.

Researchers evaluated visual acuity and optimized visual image quality in individuals with Down syndrome.

ALTO-101 is an investigational phosphodiesterase-4 inhibitor delivered via a transdermal patch.

Researchers examined the safety and efficacy of memantine for treating social impairments in youths with ASD in a 12-week placebo-controlled randomized clinical trial.

Researchers investigate the role of noninvasive brain stimulation modalities in the treatment of patients with ADHD.

For many autism experts, the quality of the NIH’s selections stood in sharp contrast to the unproven claims made by administration figures.

Researchers enrolled 475 children in a longitudinal study who underwent evaluation at 3 time points between 2 and 12 years of age.

Kenvue, the parent company of Tylenol, issued a statement after an old and now-deleted 2017 social media post resurfaced suggesting it did not recommend “any of our products while pregnant.”

Some scientists say leucovorin shows promise for children who are folate-deficient, but they warn that the data is limited.

The announcement comes after a recently published review showed an association between prenatal acetaminophen exposure and an increased risk of autism.

Researchers examined associations between dose and duration of POA exposure during pregnancy and ASD or ADHD in children in cohorts with 1,267,978 and 918,177 children, respectively.

Researchers examined potential interactions between sex and diagnosis across a range of variables to compare men and women with SZ and BD.

Investigators conducted an online survey of 1369 participants with autism to understand factors contributing to suicidal thoughts.

The findings are from a nationally representative survey co-sponsored by the National Center for Health Statistics and the Agency for Healthcare Research and Quality.

Researchers used data from the 2021 National Survey of Student Engagement to compare rates of anxiety and depression, as well as gender differences, between students with and without autism from 342 universities in the United States and Canada.

Researchers assessed whether parental occupational exposures affect autism severity risk.

Investigators conducted a prospective 48-week longitudinal, web-based, cohort questionnaire study involving adults with bipolar disorder in Japan who were employed or on sick leave.

The randomized, double-blind, CONVOKE trial evaluated the safety and efficacy of CT-155, a PDT that provides interactive psychosocial intervention techniques via a smartphone app.

Investigators examined the effects of drug treatment for ADHD on suicidal behaviors, substance misuse, accidental injuries, transport accidents, and criminality in an emulation of target trials involving people aged 6 to 64 years with a new diagnosis of ADHD.

Using the exploration, preparation, implementation, sustainment framework, researchers characterized the gap between autism research and policy interventions.

Researchers examined peripartum hippocampal and amygdalar changes and assessed whether these changes were linked to childbirth experience and depression symptoms.

Researchers conducted a retrospective cohort study to assess temporal trends in the association between central precocious puberty and psychiatric disorder diagnoses.